1.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 20050100, NCT00352703
|
|
2.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 65
Sponsor:
Protocol IDs: VU-CNS-1, NCI-V85-0222
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCSD-88612, NCI-V89-0023
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AHOD0121, NCT00070187, AHOD0121
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UTHSC-9235011015, SACI-IDD-003, UTHSC-IDD-003, NCI-V93-0321
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9305, NCT00002545, RTOG-93-05
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI
Protocol IDs: SWOG-9321, CLB-9312, E-S9321, INT-0141, NCT00002548
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-5A93, NCT00002556, E5A93
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: MRC-LEUK-MYEL-VII, EU-94030, NCT00002599
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-937252, SWOG-9503, NCCTG-93-72-52
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 16
Sponsor:
Protocol IDs: EORTC-26882, NCT00002620
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 to 74
Sponsor: Other
Protocol IDs: MRC-LEUK-MYEL-VIII, EU-94031, NCT00002653
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-2394, SWOG-9508, E2394
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 61 to 80
Sponsor:
Protocol IDs: EORTC-06954, ITA-GIMEMA-AML13, NCT00002719
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-96015A1, NCI-V96-0881, NCT00002766
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-S9623, CLB-9640, E-S9623, NCT00002772, S9623
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GP-100-9501, NCI-V96-0952
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 59
Sponsor: NCI
Protocol IDs: MDA-DM-95121, NCI-V96-1010, NCT00002835
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: MDA-DM-95047, NCI-G96-1014, NCT00002836
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: NCI-D78-001-118, UF-777
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor:
Protocol IDs: BNLI-LY02, EU-98039, NCT00003578
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HEALTHONE-43892, HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 65
Sponsor: Other
Protocol IDs: SNLG-NHL-V(a), EU-98032, NCT00003815
|
